Lv5
1150 积分 2023-07-24 加入
Solamargine improves the therapeutic efficacy of anti-PD-L1 in lung adenocarcinoma by inhibiting STAT1 activation
7天前
已完结
Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma
7天前
已完结
Echinacoside inhibits tumor immune evasion by downregulating inducible PD-L1 and reshaping tumor immune landscape in breast and colorectal cancer
18天前
已完结
Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma
18天前
已关闭
The potential role of PD-1/PD-L1 small molecule inhibitors in colorectal cancer with different mechanisms of action
1个月前
已完结
Advances in cancer immunotherapy using small-molecular inhibitors targeting the PD-1/PD-L1 interaction
1个月前
已完结
Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020–2024)
1个月前
已完结
Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma
1个月前
已完结
Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma
1个月前
已完结
OXPHOS inhibitors, metabolism and targeted therapies in cancer
1个月前
已完结
皖公网安备34019202002308
